Eli Lilly and Co. (NYSE:LLY), is reportedly willing to pay as much as $3.7 billion to acquire a Cambridge, Mass.-based biotech company with a troubled leukemia drug, according to United Kingdom newspaper The Daily Mail. Eli Lilly & Co. (NYSE:LLY), stock opened the session at $54.26, and closed the session at $54.23. The 52 week range of the LLY stock remained $47.53 – $58.40 and the day range was $53.86 – $54.53.
www.gaininggreen.com/...o-nysemrk-eli-lilly-co-nyselly/126637/
www.google.de/#q=ariad+massachusetts
1+1 =2
KK